Extended release tiagabine formulations with reduced side-effects

Extended release tiagabine formulations that demonstrate fewer side-effects when administered to a patient. An extended release formulation comprising 0.5 to 30 wt.% tiagabine combined in a matrix with 15 to 80 wt.% of a hydrophilic polymer selected from the group consisting of high molecular weight...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	APFELBAUM, KATHLEEN M, ALVAREZ, FRANCISCO J, BROWN, DAVID M, GUSTAVSON, LINDA E, SLADE, RUSSELL T
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!